Novel therapeutic targets for cholestatic and fatty liver disease | Gut

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Recent advances in clinical practice

Novel therapeutic targets for cholestatic and fatty liver disease

Online download statistics by month:

Online download statistics by month: October 2021 to March 2024

	Abstract	Full	Pdf
Oct 2021	1368	1355	1420
Nov 2021	1294	1290	562
Dec 2021	1217	1227	549
Jan 2022	645	621	363
Feb 2022	501	497	238
Mar 2022	561	562	241
Apr 2022	903	906	305
May 2022	507	522	250
Jun 2022	382	376	183
Jul 2022	372	357	214
Aug 2022	383	371	217
Sep 2022	426	429	257
Oct 2022	491	479	209
Nov 2022	351	329	185
Dec 2022	313	305	196
Jan 2023	291	283	152
Feb 2023	379	356	205
Mar 2023	368	358	217
Apr 2023	292	271	171
May 2023	328	316	204
Jun 2023	246	230	128
Jul 2023	311	308	149
Aug 2023	236	235	121
Sep 2023	244	241	141
Oct 2023	266	237	160
Nov 2023	202	174	110
Dec 2023	217	200	160
Jan 2024	236	237	242
Feb 2024	266	257	179
Mar 2024	406	386	351
Total	14002	13715	8079